Physician profile
Maria E Mora
NPI 1043238132
$1,540.29
in general payments reported to CMS, 2019-2025
18 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $235 · 2021: $391 · 2022: $78.68 · 2023: $205 · 2024: $130 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $371.45 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Pfizer INC. | $196.74 | 2019-2025 | |
| Cranial Technologies, INC | $177.29 | 2021-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $135.73 | 2019-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Tris Pharma INC | $122.12 | 2019-2025 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $106.72 | 2019-2022 | |
| Corium, LLC | $91.64 | 2021-2023 | Azstarys |
| Sanofi Pasteur INC. | $73.29 | 2022-2024 | |
| Ironshore Pharmaceuticals INC. | $48.66 | 2019-2021 | |
| Phadia US INC. | $36.47 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $35.91 | 2021-2022 | |
| Adlon Therapeutics L.P. | $29.51 | 2020-2021 | |
| Genentech USA, INC. | $23.17 | 2019 | |
| Collegium Pharmaceutical, INC. | $21.63 | 2025 | Jornay Pm |
| Sarepta Therapeutics, INC. | $19.77 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.49 | 2019 | |
| Jazz Pharmaceuticals INC. | $16.38 | 2019 | |
| Neos Therapeutics, Lp | $16.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Mora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.